Who Buys Norfloxacin from India — 460 Importers Behind a $8.3M Market
India's norfloxacin import market is served by 460 active buyers who collectively imported $8.3M across 1,394 shipments. AO RANBAXY (RUSSIA) leads with a 8.5% market share, followed by ETHIOPIAN PHARMACEUTICALS SUPPLY and HINCUS PHARMACEUTICALS.. The top 5 buyers together control 22.9% of total import value, reflecting a moderately competitive buyer landscape.

Top Norfloxacin Importers — Ranked by Import Value
AO RANBAXY (RUSSIA) is the leading norfloxacin importer from India, holding a 8.5% share of the $8.3M market across 1,394 shipments from 460 buyers. The top 5 buyers — AO RANBAXY (RUSSIA), ETHIOPIAN PHARMACEUTICALS SUPPLY (ETHIOPIA), HINCUS PHARMACEUTICALS. (RUSSIA), GALAXY PHARMACEUTIQUE CORP (CONGO), AO "RANBAXY" (RUSSIA) — collectively control 22.9% of total import value.
Top Norfloxacin Buyers & Importers
Ranked by import value · 460 active buyers · Indian Customs (DGFT) data
| # | Buyer & Formulations | Value | Suppliers | Share |
|---|---|---|---|---|
| 1 | AO RANBAXYRUSSIA | $700.2K | 5 | 8.5% |
| 2 | ETHIOPIAN PHARMACEUTICALS SUPPLYETHIOPIA NORFLOXACIN TABLETES BP 400 MG 10X10 EACNORFLOXACIN 400 MG ( EACH TABLET CONTAINNORFLOXACIN 400MG | $477.7K | 5 | 5.8% |
| 3 | HINCUS PHARMACEUTICALS.RUSSIA | $299.3K | 5 | 3.6% |
| 4 | GALAXY PHARMACEUTIQUE CORPCONGO NORMET 100/100 MG SUSPENSION 30 ML BT | $231.9K | 5 | 2.8% |
| 5 | AO "RANBAXY"RUSSIA | $183.8K | 5 | 2.2% |
| 6 | GALAXY PHARMACEUTIQUE CORP.CONGO DR NORMET 100/100 MG SUSPENSION 30 ML BT | $167.2K | 5 | 2.0% |
| 7 | HEKO PHARMACY LTDTANZANIA NORFLOXACIN WITH TINIDAZOLE TABLETS ( NONORFLOXACIN WITH TINIDAZOLE TABLETS NOSNORFLOXACIN WITH TINIDAZOLE TABLETS NO | $165.5K | 5 | 2.0% |
| 8 | APOTEX PTY LTD.,AUSTRALIA | $127.9K | 5 | 1.5% |
| 9 | MYITTAR AHLINN YAUNG CO LTDMYANMAR NORFLOXACIN TABLETS BPNORLOX 400 NORFLOXACIN BP 400MG 2000000NOSNORILOX ) ( 10X1 | $123.2K | 5 | 1.5% |
| 10 | JDS CO., LTDMYANMAR NORFLOXACIN TABLETS BPNORLOX 400 NORFLOXACIN BP 400MG 2000000NOSNORILOX ) ( 10X1 | $115.8K | 5 | 1.4% |
| 11 | MEDICO PLUSCONGO DR NORFLOXACIN WITH TINIDAZOLE TABLETS ( NONORFLOXACIN WITH TINIDAZOLE TABLETS NOSNORMET 100/100 MG SUSPENSION 30 ML BT | $97.6K | 5 | 1.2% |
| 12 | PRINCE PHARMACONGO NORFLOXACIN WITH TINIDAZOLE TABLETS ( NONORFLOXACIN WITH TINIDAZOLE TABLETS NOSNORFLOXACIN & METRONIDAZOLE TABLETS UNITS : 10X1X10 TAB | $88.8K | 5 | 1.1% |
| 13 | HINCUS PHARMACEUTICALSRUSSIA | $86.1K | 5 | 1.0% |
| 14 | M/S. RAHMAN WALI LTD,PAKISTAN NORFLOXACIN TABLETS BPNORLOX 400 NORFLOXACIN BP 400MG 2000000NOSCIN-TRO SUSPENSION B/NO.AS240087A TO AS240090A | $85.3K | 5 | 1.0% |
| 15 | INTIFAC ENTERPRISESSOMALIA FORMET PLUS SUSPENSION 100ML METRONIDAZOLE + NORFLOXACINMETROFLOX SUSPENSION 100ML METRONIDAZOLE + NORFLOXACIN | $80.4K | 5 | 1.0% |
Related Analysis
Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Which companies are buying Norfloxacin — and from which countries?
Flow of Norfloxacin exports from India: each country's share and the named importers behind the numbers
Norfloxacin — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Market Analysis: Top Importing Countries & Their Importers
1Russia
Russia emerges as the first largest importing country, achieving a total trade value of $1.3M through 31 shipments. This represents a market share of 15.4% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Russia has a diverse importer base, with their top importers including:
• AO RANBAXY - $700.2K (55.2% of country's total business)
• HINCUS PHARMACEUTICALS. - $299.3K (23.6% of country's total business)
• AO "RANBAXY" - $183.8K (14.5% of country's total business)
• HINCUS PHARMACEUTICALS - $86.1K (6.8% of country's total business)
Key Insight: Russia demonstrates strong market positioning with an average shipment value of $40.9K, indicating premium pricing strategy compared to the market average of $5.9K.
Russia is a key market for Norfloxacin imports, representing 15.4% of total trade value.
2Ethiopia
Ethiopia emerges as the second largest importing country, achieving a total trade value of $1.0M through 4 shipments. This represents a market share of 12.4% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Ethiopia has a diverse importer base, with their top importers including:
• ETHIOPIAN PHARMACEUTICALS SUPPLY - $477.7K (46.6% of country's total business)
Key Insight: Ethiopia demonstrates strong market positioning with an average shipment value of $256.3K, indicating premium pricing strategy compared to the market average of $5.9K.
Ethiopia is a key market for Norfloxacin imports, representing 12.4% of total trade value.
3Afghanistan
Afghanistan emerges as the third largest importing country, achieving a total trade value of $640.7K through 8 shipments. This represents a market share of 7.8% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Afghanistan has a diverse importer base, with their top importers including:
• SHAMS NOORI PHARMA TRADING COMPANY. - $77.7K (12.1% of country's total business)
Key Insight: Afghanistan demonstrates strong market positioning with an average shipment value of $80.1K, indicating premium pricing strategy compared to the market average of $5.9K.
Afghanistan is a key market for Norfloxacin imports, representing 7.8% of total trade value.
4Congo Dr
Congo Dr emerges as the fourth largest importing country, achieving a total trade value of $509.7K through 33 shipments. This represents a market share of 6.2% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Congo Dr has a diverse importer base, with their top importers including:
• GALAXY PHARMACEUTIQUE CORP. - $167.2K (32.8% of country's total business)
• MEDICO PLUS - $97.6K (19.2% of country's total business)
Key Insight: Congo Dr demonstrates strong market positioning with an average shipment value of $15.4K, indicating premium pricing strategy compared to the market average of $5.9K.
Congo Dr is a key market for Norfloxacin imports, representing 6.2% of total trade value.
5Myanmar
Myanmar emerges as the fifth largest importing country, achieving a total trade value of $487.7K through 9 shipments. This represents a market share of 5.9% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Myanmar has a diverse importer base, with their top importers including:
• MYITTAR AHLINN YAUNG CO LTD - $123.2K (25.3% of country's total business)
• JDS CO., LTD - $115.8K (23.8% of country's total business)
Key Insight: Myanmar demonstrates strong market positioning with an average shipment value of $54.2K, indicating premium pricing strategy compared to the market average of $5.9K.
Myanmar is a key market for Norfloxacin imports, representing 5.9% of total trade value.
Buyer Segment Analysis
TransData Nexus Norfloxacin buyer market intelligence
1Buyer Segment Analysis
The 460 buyers of Norfloxacin from India can be categorized into several segments:
1. Distributors: Entities that purchase large quantities to supply to various retailers and healthcare facilities. For instance, AO RANBAXY in Russia, the top buyer with imports totaling $0.70 million, likely operates as a distributor, supplying Norfloxacin across multiple channels.
2. Government Procurement Agencies: Organizations responsible for acquiring medicines for public health programs. The Ethiopian Pharmaceuticals Supply Agency, importing $0.48 million worth of Norfloxacin, exemplifies this segment, procuring for national healthcare initiatives.
3. Hospital Groups: Large healthcare providers that import directly to meet patient needs. HINCUS PHARMACEUTICALS in Russia, with imports of $0.30 million, may represent this category, supplying directly to hospital networks.
4. Retail Chains: Pharmacy chains that import to stock their outlets. HEKO PHARMACY LTD in Tanzania, importing $0.17 million, likely falls into this segment, distributing Norfloxacin across its retail locations.
5. Re-exporters: Companies that import with the intent to export to other markets. GALAXY PHARMACEUTIQUE CORP in Congo, with imports totaling $0.23 million, may engage in re-exporting activities within the region.
6. Contract Manufacturers: Firms that import raw materials or bulk formulations to produce finished products. APOTEX PTY LTD. in Australia, importing $0.13 million, could be involved in such manufacturing processes.
Typical buying behaviors vary by segment. Distributors and government agencies often place large, periodic orders to maintain stock levels, while hospital groups and retail chains may order more frequently but in smaller quantities to meet immediate demand. Re-exporters' purchasing patterns depend on external market demands, and contract manufacturers' orders align with their production schedules.
Country-Specific Import Regulations
TransData Nexus Norfloxacin buyer market intelligence
1Country-Specific Import Regulations
For the top five importing countries, the import regulations for Norfloxacin are as follows:
1. Russia:
2. Ethiopia:
3. Afghanistan:
4. Democratic Republic of Congo (DRC):
5. Myanmar:
Demand Drivers & Market Opportunity
TransData Nexus Norfloxacin buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Norfloxacin in importing countries is driven by several factors:
1. Disease Prevalence: Norfloxacin is commonly used to treat bacterial infections such as urinary tract infections and gastroenteritis. High incidence rates of these conditions in countries like Ethiopia and Myanmar contribute to increased demand.
2. Government Healthcare Programs: Many countries have initiatives to improve access to essential medicines. For example, Ethiopia's Health Extension Program aims to provide comprehensive primary healthcare, including antibiotics like Norfloxacin.
3. Universal Health Coverage Expansion: Efforts to achieve universal health coverage in countries like the DRC and Afghanistan have led to increased procurement of essential medicines to meet the healthcare needs of the population.
4. WHO Essential Medicines List Procurement: Norfloxacin is included in the WHO Model List of Essential Medicines, guiding countries in their procurement decisions to ensure the availability of critical medications.
5. Tender-Based Purchasing: Government and international organizations often use tender systems to procure medicines. The Ethiopian Pharmaceuticals Supply Agency, for instance, utilizes tenders to acquire antibiotics, ensuring cost-effectiveness and supply chain efficiency.
With 460 buyers across 96 countries, the market for Norfloxacin from India demonstrates significant global reach and sustained demand, presenting ongoing opportunities for exporters.
Common Questions — Norfloxacin Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest norfloxacin buyer importing from India?
Based on import volume and value, AO RANBAXY (RUSSIA) leads with $700.2K in imports and a 8.5% market share — the highest of any single norfloxacin importer. ETHIOPIAN PHARMACEUTICALS SUPPLY (ETHIOPIA) and HINCUS PHARMACEUTICALS. (RUSSIA) are the next largest buyers.
QHow many companies buy norfloxacin from India?
There are 460 active norfloxacin buyers importing from India, with a combined market of $8.3M across 1,394 shipments to 96 countries. The top 5 buyers hold 22.9% of total import value, while the remaining 455 buyers handle the other 77.1%.
QWhich countries import the most norfloxacin from India?
The top importing countries for norfloxacin from India are Russia (15.4%), Ethiopia (12.4%), Afghanistan (7.8%), Congo Dr (6.2%), Myanmar (5.9%). These markets represent the largest demand centres for Indian pharmaceutical exports of norfloxacin, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for norfloxacin from India?
The average import transaction value for norfloxacin from India is $5.9K, with an average unit price of $6.87 per unit. Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
Buyer Segment Analysis
TransData Nexus Norfloxacin buyer market intelligence
1Buyer Segment Analysis
The 460 buyers of Norfloxacin from India can be categorized into several segments:
1. Distributors: Entities that purchase large quantities to supply to various retailers and healthcare facilities. For instance, AO RANBAXY in Russia, the top buyer with imports totaling $0.70 million, likely operates as a distributor, supplying Norfloxacin across multiple channels.
2. Government Procurement Agencies: Organizations responsible for acquiring medicines for public health programs. The Ethiopian Pharmaceuticals Supply Agency, importing $0.48 million worth of Norfloxacin, exemplifies this segment, procuring for national healthcare initiatives.
3. Hospital Groups: Large healthcare providers that import directly to meet patient needs. HINCUS PHARMACEUTICALS in Russia, with imports of $0.30 million, may represent this category, supplying directly to hospital networks.
4. Retail Chains: Pharmacy chains that import to stock their outlets. HEKO PHARMACY LTD in Tanzania, importing $0.17 million, likely falls into this segment, distributing Norfloxacin across its retail locations.
5. Re-exporters: Companies that import with the intent to export to other markets. GALAXY PHARMACEUTIQUE CORP in Congo, with imports totaling $0.23 million, may engage in re-exporting activities within the region.
6. Contract Manufacturers: Firms that import raw materials or bulk formulations to produce finished products. APOTEX PTY LTD. in Australia, importing $0.13 million, could be involved in such manufacturing processes.
Typical buying behaviors vary by segment. Distributors and government agencies often place large, periodic orders to maintain stock levels, while hospital groups and retail chains may order more frequently but in smaller quantities to meet immediate demand. Re-exporters' purchasing patterns depend on external market demands, and contract manufacturers' orders align with their production schedules.
Country-Specific Import Regulations
TransData Nexus Norfloxacin buyer market intelligence
1Country-Specific Import Regulations
For the top five importing countries, the import regulations for Norfloxacin are as follows:
1. Russia:
2. Ethiopia:
3. Afghanistan:
4. Democratic Republic of Congo (DRC):
5. Myanmar:
Demand Drivers & Market Opportunity
TransData Nexus Norfloxacin buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Norfloxacin in importing countries is driven by several factors:
1. Disease Prevalence: Norfloxacin is commonly used to treat bacterial infections such as urinary tract infections and gastroenteritis. High incidence rates of these conditions in countries like Ethiopia and Myanmar contribute to increased demand.
2. Government Healthcare Programs: Many countries have initiatives to improve access to essential medicines. For example, Ethiopia's Health Extension Program aims to provide comprehensive primary healthcare, including antibiotics like Norfloxacin.
3. Universal Health Coverage Expansion: Efforts to achieve universal health coverage in countries like the DRC and Afghanistan have led to increased procurement of essential medicines to meet the healthcare needs of the population.
4. WHO Essential Medicines List Procurement: Norfloxacin is included in the WHO Model List of Essential Medicines, guiding countries in their procurement decisions to ensure the availability of critical medications.
5. Tender-Based Purchasing: Government and international organizations often use tender systems to procure medicines. The Ethiopian Pharmaceuticals Supply Agency, for instance, utilizes tenders to acquire antibiotics, ensuring cost-effectiveness and supply chain efficiency.
With 460 buyers across 96 countries, the market for Norfloxacin from India demonstrates significant global reach and sustained demand, presenting ongoing opportunities for exporters.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Buyer Identification: 460 global importers of Norfloxacin identified from consignee fields in DGFT shipping bill records.
- 2.Import Value Analysis: Total import value aggregated from 1,394 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Geographic Distribution: Buyer imports distributed across 96 destination countries with market share per buyer calculated from capped values.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1,394 Verified Shipments
460 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists
